Higher systemic antibiotic consumption in a population of South Korea (2008 - 2009)

International Journal of Clinical Pharmacology and Therapeutics

Volumn 51, Issue 7, 2013, Pages 585-592

  Sohn, Hyun Soon ^a   Oh, Ock Hee E ^b   Kwon, Jin Won ^c   Lee, Young Sook ^d  

^a Sookmyung Women's University   (South Korea)

^b FirstDis Korea   (South Korea)

^c Kyungpook National University   (South Korea)

^d Keimyung University   (South Korea)

Author keywords

Antibiotic prescription; Antibiotics for systemic use; Defined daily dose; Drug consumption

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; LEVOFLOXACIN; MACROLIDE; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; TETRACYCLINE DERIVATIVE;

ACUTE SINUSITIS; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASTHMA; BRONCHITIS; CHILD; CHRONIC SINUSITIS; CONTROLLED STUDY; DRUG INDICATION; DRUG USE; GINGIVITIS; HUMAN; INFANT; LARYNGITIS; MAJOR CLINICAL STUDY; OTITIS MEDIA; PERIODONTAL DISEASE; PHARYNGITIS; PRESCHOOL CHILD; PRESCRIPTION; RESPIRATORY TRACT DISEASE; SCHOOL CHILD; SEASONAL VARIATION; SOUTH KOREA; SUPPURATIVE OTITIS MEDIA; SYSTEMIC THERAPY; TONSILLITIS; TRACHEITIS; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION ROUTES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; HEALTH CARE SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE, PHARMACEUTICAL SERVICES; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; REPUBLIC OF KOREA; SEASONS; TIME FACTORS; YOUNG ADULT;

EID: 84880208540     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201827     Document Type: Article

References (35)

1. Vlieghe E. The First Global Forum on Bacterial Infections calls for urgent action to contain antibiotic resistance. Expert Rev Anti Infect Ther. 2012; 10: 145-148. CrossRef PubMed
2. Jensen US, Muller A, Brandt CT, Frimodt-Møller N, Hammerum AM, Monnet DL; DANRES study group. Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance. J Antimicrob Chemother. 2010; 65: 1286-1291. CrossRef PubMed
3. Song YA, Jung SI, Chang MO et al. Relationship between antibiotic use and antibiotic resistance in major nosocomial pathogens at a university hospital. Chonnam Med J. 2008; 4: 37-43.
4. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365: 579-587. PubMed (Pubitemid 40247914)
5. Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat. 2000; 3: 303-311. CrossRef PubMed
6. World Health Organization. Drug resistance. Available from URL: www.who.int/drugresistance/en/index.html (accessed May 25, 2012).
7. Korea Health Industry Development Institute. Pharmaceutical Industry Analysis Report 2010. Korea Health Industry Development Institute, Seoul, Korea, 2010.
8. Health Insurance Review and Assessment Service. Statistical Indicators for 2009 Health Insurance Benefits. Available from URL: www.hira.or.kr/(accessed June 6, 2012).
9. National Health Insurance Corporation. Health Insurance Statistical Yearbook. National Health Insurance Corporation/Health Insurance Review and Assessment Service. Seoul, Korea, 2011.
10. National Health Insurance Corporation. History of National Health Insurance Policy. National Health Insurance Corporation, Seoul, Korea, 2012.
11. Chong Y, Lee K. Present situation of antimicrobial resistance in Korea. J Infect Chemother. 2000; 6: 189-195. CrossRef PubMed (Pubitemid 32052310)
12. Lee KW, Kim MY, Kang SH, Kang JO, Kim EC, Choi TY, Chong YS; Korean Nationwide Surveillance Of Antimicrobial Resistance Group. Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli. Yonsei Med J. 2003; 44: 571-578. PubMed (Pubitemid 37098875)
13. Lee EK. Analysis of the changes in antibiotic use and resistance. Forum of Health and Social Affairs. 2003; 77: 72-82.
14. Kim SK, Kim HE, Back HE et al. The Effect of Public Report on Antibiotics Prescribing Rate. Kor J Clin Pharm. 2010; 20: 242-247.
15. World Health Organization Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) Classification System: Guidelines for ATC classification and DDD assignment 2010. Oslo; WHO, 2009.
16. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H; ESAC Project Group. European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol. 2004; 58: 419-428. CrossRef PubMed (Pubitemid 39312466)
17. Hutchinson JM, Patrick DM, Marra F et al. Measurement of antibiotic consumption: A practical guide to the use of the Anatomical Therapeutic Chemical classification and Defined Daily Dose system methodology in Canada. Can J Infect Dis. 2004; 15: 29-35. (Pubitemid 38387655)
18. Population Projections. The Statistics Korea. Available from URL: http://kosis.kr/(accessed July 3, 2012).
19. Health Data OECD. 2010. OECD, Paris, 2010.
20. Health Data OECD. 2012. OECD, Paris, 2010. Available from URL: www.oecd.org. (Accessed Dec 2, 2012)
21. Patrick DM, Marra F, Hutchinson J, Monnet DL, Ng H, Bowie WR. Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe? Clin Infect Dis. 2004; 39: 11-17. CrossRef PubMed (Pubitemid 38879542)
22. Kim JH, Yoo HS, Lee JS, Lee EG, Park HK, Sung YH, Kim S, Kim HS, Shin SY, Lee JK. The spread of pandemic H1N1 2009 by age and region and the comparison among monitoring tools. J Korean Med Sci. 2010; 25: 1109-1112. CrossRef PubMed
23. Choi WS, Kim WJ, Cheong HJ. [The evaluation of policies on 2009 influenza pandemic in Korea]. J Prev Med Pub Health. 2010; 43: 105-108. CrossRef PubMed
24. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM et al; 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009; 361: 1935-1944. CrossRef PubMed
25. World Health Organization. Transcript of virtual press conference with Gregory Hartl, Spokesperson for H1N1, and Dr Nikki Shindo, Medical Officer, Global Influenza Programme. November 2009. Available from URL: www.who. i n t /me d i a c e n t r e /v p c-t r a n s c r i p t-1 2-november-09-nikki-shindo. pdf (accessed July 13, 2012)
26. Wright PF, Kirkland KB, Modlin JF. When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia. N Engl J Med. 2009; 361: e112 CrossRef PubMed
27. Lusini G, Lapi F, Sara B, Vannacci A, Mugelli A, Kragstrup J, Bjerrum L. Antibiotic prescribing in paediatric populations: a comparison between Viareggio, Italy and Funen, Denmark. Eur J Public Health. 2009; 19: 434-438. CrossRef PubMed
28. Finkelstein JA, Stille C, Nordin J, Davis R, Raebel MA, Roblin D, Go AS, Smith D, Johnson CC, Kleinman K, Chan KA, Platt R. Reduction in antibiotic use among US children, 1996-2000. Pediatrics. 2003; 112: 620-627. CrossRef PubMed (Pubitemid 37082116)
29. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TMInfectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007; 44: 159-177. CrossRef PubMed (Pubitemid 46084814)
30. Mullett CJ, Evans RS, Christenson JC, Dean JM. Development and impact of a computerized pediatric antiinfective decision support program. Pediatrics. 2001; 108: E75. CrossRef PubMed
31. Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America joint committee on the prevention of antimicrobial resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997; 25: 584-599. CrossRef PubMed (Pubitemid 127774277)
32. World Health Organization. Report on Infectious Diseases. Overcoming Antimicrobial Resistance 2000. Available from URL: www.who.int/infectious- disease-report/2000/index.html (accessed July 11, 2012).
33. Hutchinson JM, Foley RN. Method of physician remuneration and rates of antibiotic prescription. CMAJ. 1999; 160: 1013-1017. PubMed (Pubitemid 29176745)
34. Chung DR, Song JH; The Korean Society of Infectious Diseases. National campaign for appropriate antibiotic use in Korea. Infect Chemother. 2012; 44: 164-167. CrossRef
35. Kim BN. Overview of antibiotic use in Korea. Infect Chemother. 2012; 44: 250-262. CrossRef